World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
111
Citations
50763
World Ranking
5296
National Ranking
55

Overview

Gunnar H. Gislason is affiliated with Copenhagen University Hospital in Denmark. Their research output spans multiple areas within medicine, with a focus on cardiology and cardiovascular medicine.

The scientist's recent publications include:

  • Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality, 2020, JAMA
  • Cardiovascular effects and safety of (non-aspirin) NSAIDs, 2020, Nature Reviews Cardiology
  • SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study, 2021, BMJ
  • Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction, 2020, Circulation
  • Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome, 2020, Journal of the American College of Cardiology

They frequently collaborate with several co-authors, including:

  • Christian Torp-Pedersen
  • Lars Køber
  • Emil Loldrup Fosbøl
  • Tor Biering-Sørensen
  • Morten Schou

The primary publication venues for their work are:

  • European Heart Journal
  • Journal of the American College of Cardiology
  • Circulation
  • EP Europace
  • Journal of the American Heart Association

Gislason's research focuses mainly on medicine, with subfields including:

  • Cardiology and Cardiovascular Medicine
  • Epidemiology
  • Emergency Medicine
  • Endocrinology, Diabetes and Metabolism
  • Surgery

The key topics of their scientific work encompass:

  • Cardiovascular Function and Risk Factors
  • Atrial Fibrillation Management and Outcomes
  • Heart Failure Treatment and Management
  • Cardiac Imaging and Diagnostics
  • Cardiac Arrest and Resuscitation
  • Cardiac Arrhythmias and Treatments
  • Acute Myocardial Infarction Research

Best Publications

  • Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

    Jonas Bjerring Olesen;Gregory Y H Lip;Morten Lock Hansen;Peter Riis Hansen

  • Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest

    Mads Wissenberg;Freddy K. Lippert;Fredrik Folke;Peter Weeke

  • Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

    Jonas Bjerring Olesen;Gregory Y H Lip;Anne-Lise Kamper;Kristine Hommel

  • Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.

    Morten L. Hansen;Rikke Sørensen;Mette T. Clausen;Marie Louise Fog-Petersen

  • Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

    Rikke Sørensen;Morten L Hansen;Steen Z Abildstrom;Steen Z Abildstrom;Anders Hvelplund

  • Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People

    Tina Ken Schramm;Gunnar H. Gislason;Lars Køber;Søren Rasmussen

  • Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

    Gunnar H. Gislason;Søren Jacobsen;Jeppe N. Rasmussen;Søren Rasmussen

  • Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

    Jonas Bjerring Olesen;Gregory Y H Lip;Jesper Lindhardsen;Deirdre A Lane

  • Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention A Nationwide Cohort Study

    Morten Lamberts;Jonas Bjerring Olesen;Martin Huth Ruwald;Carolina Malta Hansen

  • Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.

    Tina Ken Schramm;Gunnar Hilmar Gislason;Allan Vaag;Jeppe Nørgaard Rasmussen

  • Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.

    O. Ahlehoff;G. H. Gislason;M. Charlot;C. H. Jørgensen

  • The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study

    Jesper Lindhardsen;Ole Ahlehoff;Gunnar Hilmar Gislason;Ole Rintek Madsen

  • Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction: A Nationwide Cohort Study

    Anne-Marie Schjerning Olsen;Emil L. Fosbøl;Jesper Lindhardsen;Fredrik Folke

  • Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention

    Morten Lamberts;Gunnar H. Gislason;Jonas Bjerring Olesen;Søren Lund Kristensen

  • Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.

    Emil L. Fosbøl;Jawad H. Butt;Lauge Østergaard;Charlotte Andersson

  • Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction

    Gunnar H. Gislason;Jeppe N. Rasmussen;Steen Z. Abildstrøm;Niels Gadsbøll

  • The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study

    Christian Selmer;Jonas Bjerring Olesen;Morten Lock Hansen;Jesper Lindhardsen

  • Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.

    Gunnar H. Gislason;Jeppe N. Rasmussen;Steen Z. Abildstrom;Tina K. Schramm

  • Bystander Efforts and 1-Year Outcomes in Out-of-Hospital Cardiac Arrest.

    Kristian Kragholm;Kristian Kragholm;Mads Wissenberg;Rikke N. Mortensen;Steen M. Hansen

  • Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.

    Mette Charlot;Ole Ahlehoff;Mette Lykke Norgaard;Casper H. Jørgensen

Frequent Co-Authors

Christian Torp-Pedersen
Christian Torp-Pedersen Aalborg University
Lars Køber
Lars Køber Copenhagen University Hospital
Peter Riis Hansen
Peter Riis Hansen University of Copenhagen
Lone Skov
Lone Skov University of Copenhagen
Jacob P. Thyssen
Jacob P. Thyssen University of Copenhagen
Gregory Y.H. Lip
Gregory Y.H. Lip University of Liverpool
Mark A. Hlatky
Mark A. Hlatky Stanford University
Henrik E. Poulsen
Henrik E. Poulsen University of Copenhagen
Allan Vaag
Allan Vaag Steno Diabetes Center
Jonathan M. Hodgson
Jonathan M. Hodgson Edith Cowan University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Medicine but prefer more flexible study options, numerous online degrees can help you enter or advance in healthcare. One popular path is pursuing nurse practitioner programs, which allow registered nurses to gain advanced clinical skills while working.

For those starting with an RN license, the cheapest rn to bsn online programs offer cost-effective ways to earn a Bachelor of Science in Nursing (BSN). This degree can broaden job opportunities and is a common requirement for leadership positions in nursing.

Nurses seeking to reach the highest academic level can explore the cheapest phd nursing programs online. These rigorous degrees focus on research and leadership, opening doors to careers in academia, advanced practice, or administration.

If affordability is a priority, there are many affordable rn to bsn programs designed to provide quality education without high tuition costs. Choosing a pathway that matches your career goals and budget can set you on the right trajectory in healthcare.

Best Scientists Citing Gunnar H. Gislason

Trending Scientists

Recently Published Articles